tiprankstipranks
Trending News
More News >
Medtronic (MDT)
NYSE:MDT
US Market

Medtronic (MDT) Stock Forecast & Price Target

Compare
6,438 Followers
See the Price Targets and Ratings of:

MDT Analyst Ratings

Moderate Buy
17Ratings
Moderate Buy
11 Buy
6 Hold
0 Sell
Based on 17 analysts giving stock ratings to
Medtronic
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MDT Stock 12 Month Forecast

Average Price Target

$114.08
▲(30.92% Upside)
Based on 17 Wall Street analysts offering 12 month price targets for Medtronic in the last 3 months. The average price target is $114.08 with a high forecast of $125.00 and a low forecast of $100.00. The average price target represents a 30.92% change from the last price of $87.14.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"80":"$80","103":"$103","126":"$126","91.5":"$91.5","114.5":"$114.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":125,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$125.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":114.08,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$114.08</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":100,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$100.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[80,91.5,103,114.5,126],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,98.1,100.16923076923077,102.23846153846154,104.3076923076923,106.37692307692308,108.44615384615385,110.51538461538462,112.58461538461538,114.65384615384616,116.72307692307692,118.7923076923077,120.86153846153846,122.93076923076923,{"y":125,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,98.1,99.32923076923076,100.55846153846153,101.7876923076923,103.01692307692308,104.24615384615385,105.47538461538461,106.70461538461538,107.93384615384615,109.16307692307691,110.3923076923077,111.62153846153846,112.85076923076923,{"y":114.08,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,98.1,98.24615384615385,98.39230769230768,98.53846153846153,98.68461538461538,98.83076923076922,98.97692307692307,99.12307692307692,99.26923076923077,99.41538461538461,99.56153846153846,99.70769230769231,99.85384615384615,{"y":100,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":89.21,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":86.46,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.65,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.82,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.44,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 45,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":88.02,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 46,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":91.95,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":94.12,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":90.04,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":102.58,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":96.06,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":102.71,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":98.1,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$125.00Average Price Target$114.08Lowest Price Target$100.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Needham
$120
Buy
37.71%
Upside
Assigned
03/13/26
Analysts Offer Insights on Healthcare Companies: Medtronic (NYSE: MDT) and Capricor Therapeutics (NASDAQ: CAPR)
Truist Financial Analyst forecast on MDT
Truist Financial
Truist Financial
Hold
Reiterated
03/11/26
Analysts Offer Insights on Healthcare Companies: Legend Biotech (NASDAQ: LEGN) and Medtronic (NYSE: MDT)
Barclays Analyst forecast on MDT
Barclays
Barclays
$118
Buy
35.41%
Upside
Reiterated
03/11/26
Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (NYSE: HIMS) and Medtronic (NYSE: MDT)
Citi
$117
Buy
34.27%
Upside
Reiterated
03/11/26
Medtronic (MDT) Receives a Buy from Citi
Wells Fargo Analyst forecast on MDT
Wells Fargo
Wells Fargo
$114
Buy
30.82%
Upside
Reiterated
03/11/26
Medtronic (MDT) Gets a Buy from Wells Fargo
Bank of America Securities Analyst forecast on MDT
Bank of America Securities
Bank of America Securities
$110
Buy
26.23%
Upside
Reiterated
03/09/26
Analysts Are Bullish on Top Healthcare Stocks: CG Oncology, Inc. (CGON), Stereotaxis (STXS)
TD Cowen
$106$119
Buy
36.56%
Upside
Assigned
03/08/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Mizuho Securities Analyst forecast on MDT
Mizuho Securities
Mizuho Securities
$125
Buy
43.45%
Upside
Initiated
02/18/26
Medtronic resumed with an Outperform at MizuhoMedtronic resumed with an Outperform at Mizuho
Robert W. Baird Analyst forecast on MDT
Robert W. Baird
Robert W. Baird
$103$100
Hold
14.76%
Upside
Reiterated
02/18/26
Medtronic price target lowered to $100 from $103 at BairdMedtronic price target lowered to $100 from $103 at Baird
Bernstein Analyst forecast on MDT
Bernstein
Bernstein
$112
Buy
28.53%
Upside
Reiterated
02/18/26
Analysts Are Bullish on These Healthcare Stocks: Neurosense Therapeutics Ltd. (NRSN), Immunovant (IMVT)
BTIG
Hold
Reiterated
02/18/26
BTIG Sticks to Its Hold Rating for Medtronic (MDT)
J.P. Morgan Analyst forecast on MDT
J.P. Morgan
J.P. Morgan
Hold
Reiterated
02/17/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: IDEAYA Biosciences (NASDAQ: IDYA) and Medtronic (NYSE: MDT)
UBS
$104
Hold
19.35%
Upside
Reiterated
02/17/26
Medtronic: Solid Quarter but Limited Growth Visibility Justifies Hold Rating
RBC Capital
$118
Buy
35.41%
Upside
Reiterated
02/17/26
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (NASDAQ: GILD), Medtronic (NYSE: MDT) and Camurus AB (Other OTC: CAMRF)
William Blair Analyst forecast on MDT
William Blair
William Blair
Buy
Reiterated
02/17/26
Analysts Conflicted on These Healthcare Names: Masimo (NASDAQ: MASI) and Medtronic (NYSE: MDT)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Needham
$120
Buy
37.71%
Upside
Assigned
03/13/26
Analysts Offer Insights on Healthcare Companies: Medtronic (NYSE: MDT) and Capricor Therapeutics (NASDAQ: CAPR)
Truist Financial Analyst forecast on MDT
Truist Financial
Truist Financial
Hold
Reiterated
03/11/26
Analysts Offer Insights on Healthcare Companies: Legend Biotech (NASDAQ: LEGN) and Medtronic (NYSE: MDT)
Barclays Analyst forecast on MDT
Barclays
Barclays
$118
Buy
35.41%
Upside
Reiterated
03/11/26
Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (NYSE: HIMS) and Medtronic (NYSE: MDT)
Citi
$117
Buy
34.27%
Upside
Reiterated
03/11/26
Medtronic (MDT) Receives a Buy from Citi
Wells Fargo Analyst forecast on MDT
Wells Fargo
Wells Fargo
$114
Buy
30.82%
Upside
Reiterated
03/11/26
Medtronic (MDT) Gets a Buy from Wells Fargo
Bank of America Securities Analyst forecast on MDT
Bank of America Securities
Bank of America Securities
$110
Buy
26.23%
Upside
Reiterated
03/09/26
Analysts Are Bullish on Top Healthcare Stocks: CG Oncology, Inc. (CGON), Stereotaxis (STXS)
TD Cowen
$106$119
Buy
36.56%
Upside
Assigned
03/08/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Mizuho Securities Analyst forecast on MDT
Mizuho Securities
Mizuho Securities
$125
Buy
43.45%
Upside
Initiated
02/18/26
Medtronic resumed with an Outperform at MizuhoMedtronic resumed with an Outperform at Mizuho
Robert W. Baird Analyst forecast on MDT
Robert W. Baird
Robert W. Baird
$103$100
Hold
14.76%
Upside
Reiterated
02/18/26
Medtronic price target lowered to $100 from $103 at BairdMedtronic price target lowered to $100 from $103 at Baird
Bernstein Analyst forecast on MDT
Bernstein
Bernstein
$112
Buy
28.53%
Upside
Reiterated
02/18/26
Analysts Are Bullish on These Healthcare Stocks: Neurosense Therapeutics Ltd. (NRSN), Immunovant (IMVT)
BTIG
Hold
Reiterated
02/18/26
BTIG Sticks to Its Hold Rating for Medtronic (MDT)
J.P. Morgan Analyst forecast on MDT
J.P. Morgan
J.P. Morgan
Hold
Reiterated
02/17/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: IDEAYA Biosciences (NASDAQ: IDYA) and Medtronic (NYSE: MDT)
UBS
$104
Hold
19.35%
Upside
Reiterated
02/17/26
Medtronic: Solid Quarter but Limited Growth Visibility Justifies Hold Rating
RBC Capital
$118
Buy
35.41%
Upside
Reiterated
02/17/26
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (NASDAQ: GILD), Medtronic (NYSE: MDT) and Camurus AB (Other OTC: CAMRF)
William Blair Analyst forecast on MDT
William Blair
William Blair
Buy
Reiterated
02/17/26
Analysts Conflicted on These Healthcare Names: Masimo (NASDAQ: MASI) and Medtronic (NYSE: MDT)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Medtronic

3 Months
xxx
Success Rate
17/23 ratings generated profit
74%
Average Return
+3.88%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 73.91% of your transactions generating a profit, with an average return of +3.88% per trade.
1 Year
Matt MiksicBarclays
Success Rate
24/36 ratings generated profit
67%
Average Return
+6.51%
a rating ―
Copying Matt Miksic's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +6.51% per trade.
2 Years
xxx
Success Rate
12/17 ratings generated profit
71%
Average Return
+8.59%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 70.59% of your transactions generating a profit, with an average return of +8.59% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MDT Analyst Recommendation Trends

Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
0
0
0
0
0
Buy
33
34
27
30
29
Hold
16
23
21
20
13
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
49
57
48
50
42
In the current month, MDT has received 29 Buy Ratings, 13 Hold Ratings, and 0 Sell Ratings. MDT average Analyst price target in the past 3 months is 114.08.
Each month's total comprises the sum of three months' worth of ratings.

MDT Financial Forecast

MDT Earnings Forecast

Next quarter’s earnings estimate for MDT is $1.67 with a range of $1.66 to $1.70. The previous quarter’s EPS was $1.36. MDT beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year MDT has Performed in-line its overall industry.
Next quarter’s earnings estimate for MDT is $1.67 with a range of $1.66 to $1.70. The previous quarter’s EPS was $1.36. MDT beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year MDT has Performed in-line its overall industry.

MDT Sales Forecast

Next quarter’s sales forecast for MDT is $9.66B with a range of $9.61B to $9.71B. The previous quarter’s sales results were $9.02B. MDT beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year MDT has Performed in-line its overall industry.
Next quarter’s sales forecast for MDT is $9.66B with a range of $9.61B to $9.71B. The previous quarter’s sales results were $9.02B. MDT beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year MDT has Performed in-line its overall industry.

MDT Stock Forecast FAQ

What is MDT’s average 12-month price target, according to analysts?
Based on analyst ratings, Medtronic’s 12-month average price target is 114.08.
    What is MDT’s upside potential, based on the analysts’ average price target?
    Medtronic has 30.92% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is MDT a Buy, Sell or Hold?
          Medtronic has a consensus rating of Moderate Buy which is based on 11 buy ratings, 6 hold ratings and 0 sell ratings.
            What is Medtronic’s price target?
            The average price target for Medtronic is 114.08. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $125.00 ,the lowest forecast is $100.00. The average price target represents 30.92% Increase from the current price of $87.14.
              What do analysts say about Medtronic?
              Medtronic’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 17 Wall Streets Analysts.
                How can I buy shares of MDT?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.